Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
APOBEC3G (A3G), a deoxycytidine deaminase, is a potent host antiviral factor that can restrict HIV-1 infection. During Vif-negative HIV-1 replication, A3G is incorporated into HIV-1 particles, induces mutations in reverse transcribed viral DNA and inhibits reverse transcription. However, HIV-1 Vif c...
Main Authors: | Zhujun Ao, Zhe Yu, Lina Wang, Yingfeng Zheng, Xiaojian Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-04-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2288674?pdf=render |
Similar Items
-
The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G
by: Presnyak Vlad, et al.
Published: (2007-11-01) -
Towards Inhibition of Vif-APOBEC3G Interaction: Which Protein to Target?
by: Iris Cadima-Couto, et al.
Published: (2010-01-01) -
Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein
by: Benjamin Stupfler, et al.
Published: (2021-04-01) -
Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface
by: Michael Letko, et al.
Published: (2015-12-01) -
Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I
by: Maria Yousefi, et al.
Published: (2023-02-01)